Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

One of the best moments from the show included Carpenter's monologue and one of the worst moments included the singer's mic cutting out during a sketch SNL airs at 11:30 p.m. EST / 8:30 p.m. PST on ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

This is your first of three free stories this month. Become a free or sustaining member to read unlimited articles, webinars and ebooks. We keep calling for transit-oriented development (TOD) — or ...

From Ricky Martin to Janet Jackson to Lil Nas X to Madonna, not even celebrities are exempt from experiencing a wardrobe malfunction. This has happened to a lot of singers who had their outfits ...

Joe Grantham is a contributor from the UK with a degree in Classical Studies. His love for gaming is only rivaled by a deep passion for medieval history, which often seeps into his articles. With over ...

The good, the bad and the WTF style moments celebrities served up this week Catherine Santino is a Style Writer-Reporter at PEOPLE. She began as a contributor for PEOPLE in 2022 and joined the staff ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...